Vaccine Development Builds on COVID-19 Breakthroughs: Advances in vaccine development are creating partnerships and stimulating clinical trials to develop new mRNA applications

Wechsler, J.

Wechsler, J..

BioPharm International ; 36(3):8-9, 2023.

Article in English | EMBASE | ID: covidwho-2286435

Keywords

clinical trial (topic), coronavirus disease 2019, disease severity, drug approval, drug industry, drug safety, Food and Drug Administration, government, health care personnel, health care policy, human, Human immunodeficiency virus infection, immunization, immunogenicity, infection, influenza, interpersonal communication, malaria, melanoma, misinformation, note, pandemic, pneumococcal infection, politics, respiratory syncytial virus infection, Severe acute respiratory syndrome coronavirus 2, vaccination, vaccine development, vaccine hesitancy, virus strain, Zika fever, influenza vaccine, messenger RNA, SARS-CoV-2 vaccine

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Topics: Vaccines Language: English Journal: BioPharm International Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML